News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biothera Names Patricia Molloy, M.D., Chief Medical Officer


11/21/2011 9:12:07 AM

EAGAN, Minn.--(BUSINESS WIRE)--Biothera today announced the appointment of Patricia Molloy, M.D. as Chief Medical Officer. In this role, Dr. Molloy is responsible for the clinical development of Imprime PGG®, the company’s immunotherapeutic oncology drug that is currently in multiple clinical trials for colorectal and lung cancer and chronic lymphocytic leukemia.

Read at BioSpace.com

comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES